Assertio Therapeutics Inc:企業の戦略・SWOT・財務分析

【英語タイトル】Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(SWOT20MY4580)・商品コード:SWOT20MY4580
・発行会社(調査会社):MarketLine
・発行日:2020年2月
・ページ数:46
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report
Summary

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralgia caused by viral infection, herpes zoster, or nerve damage; management of mild to moderate acute pain in adults; migraine attacks in adults of 18 years of age or above; and pain in cancer patients of 18 years of age and older. The company sells its products to wholesale distributors and retail pharmacies. Assertio also licenses Acuform, its proprietary gastroretentive drug delivery technology. Assertio is headquartered in Lake Forest, Illinois, the US.

Scope

- Detailed information on Assertio Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Assertio Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Assertio Therapeutics Inc including a breakdown and examination of key business segments
- Intelligence on Assertio Therapeutics Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Assertio Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Assertio Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Assertio Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Assertio Therapeutics Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Assertio Therapeutics Inc: Company Overview
Assertio Therapeutics Inc: Overview and Key Facts
Assertio Therapeutics Inc: Overview
Assertio Therapeutics Inc: Key Facts
Assertio Therapeutics Inc: Key Employees
Assertio Therapeutics Inc: Key Employee Biographies
Assertio Therapeutics Inc: Major Products and Services
Assertio Therapeutics Inc: Company History
Assertio Therapeutics Inc: Management Statement
Assertio Therapeutics Inc: Locations and Subsidiaries
Assertio Therapeutics Inc: Key Competitors
Assertio Therapeutics Inc: Company Analysis
Assertio Therapeutics Inc: Business Description
Assertio Therapeutics Inc: SWOT Analysis
Assertio Therapeutics Inc: SWOT Overview
Assertio Therapeutics Inc: Strengths
Assertio Therapeutics Inc: Weaknesses
Assertio Therapeutics Inc: Opportunities
Assertio Therapeutics Inc: Threats
Assertio Therapeutics Inc: Corporate Financial Deals Activity
Assertio Therapeutics Inc: Financial Deals Overview
Assertio Therapeutics Inc: Top Deals 2016 – 2020YTD*
Assertio Therapeutics Inc: Advisors
Assertio Therapeutics Inc: Top Legal Advisors
Assertio Therapeutics Inc: Top Financial Advisors
Assertio Therapeutics Inc: Mergers and Acquisitions
Assertio Therapeutics Inc: Partnership
Assertio Therapeutics Inc: Divestments
Assertio Therapeutics Inc: Recent Developments
Assertio Therapeutics Inc: News and Events Summary
Assertio Therapeutics Inc: Business Expansion
Assertio Therapeutics Inc: Corporate Governance
Assertio Therapeutics Inc: Financial Performance
Assertio Therapeutics Inc: Regulatory and Legal Events
Assertio Therapeutics Inc: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Assertio Therapeutics Inc: Key Facts
Table 2: Assertio Therapeutics Inc: Key Employees
Table 3: Assertio Therapeutics Inc: Company History
Table 4: Assertio Therapeutics Inc: Locations and Subsidiaries
Table 5: Assertio Therapeutics Inc: Key Competitors
Table 6: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Assertio Therapeutics Inc: M&A Average Deal Size - Value (US$m)
Table 9: Assertio Therapeutics Inc: Top Deals 2016 - 2020YTD*
Table 10: Assertio Therapeutics Inc: Legal Advisor Ranking by Value (US$m)
Table 11: Assertio Therapeutics Inc: Financial Advisor Ranking by Value (US$m)
Table 12: Assertio Therapeutics Inc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Assertio Therapeutics Inc: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Assertio Therapeutics Inc: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Assertio Therapeutics Inc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 16: Assertio Therapeutics Inc: News and Events Summary
Table 17: Assertio Therapeutics Inc: Business Expansion
Table 18: Assertio Therapeutics Inc: Corporate Governance
Table 19: Assertio Therapeutics Inc: Financial Performance
Table 20: Assertio Therapeutics Inc: Regulatory and Legal Events
Table 21: Assertio Therapeutics Inc: Research & Development

★調査レポート[Assertio Therapeutics Inc:企業の戦略・SWOT・財務分析] (コード:SWOT20MY4580)販売に関する免責事項を必ずご確認ください。
★調査レポート[Assertio Therapeutics Inc:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆